Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vesico-Ureteral Reflux | 12 | 2021 | 437 | 2.580 |
Why?
|
Urinary Tract Infections | 8 | 2021 | 802 | 2.040 |
Why?
|
Hydronephrosis | 5 | 2023 | 271 | 1.970 |
Why?
|
Ureteral Obstruction | 8 | 2022 | 293 | 1.940 |
Why?
|
Glycomics | 3 | 2021 | 113 | 1.730 |
Why?
|
Tandem Mass Spectrometry | 8 | 2021 | 1188 | 1.330 |
Why?
|
Urine | 5 | 2020 | 362 | 1.200 |
Why?
|
Polysaccharides | 7 | 2021 | 1014 | 1.110 |
Why?
|
Nephrectomy | 5 | 2018 | 937 | 1.050 |
Why?
|
Urinary Tract | 7 | 2019 | 313 | 1.030 |
Why?
|
Proteomics | 10 | 2021 | 3849 | 1.030 |
Why?
|
Urologic Diseases | 5 | 2019 | 247 | 1.030 |
Why?
|
Kidney | 13 | 2023 | 7048 | 1.000 |
Why?
|
Robotics | 7 | 2010 | 819 | 1.000 |
Why?
|
Glycoproteins | 5 | 2016 | 2203 | 0.920 |
Why?
|
Glycosylation | 6 | 2021 | 1098 | 0.840 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 72 | 0.810 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 60 | 0.810 |
Why?
|
Proteome | 3 | 2020 | 1862 | 0.810 |
Why?
|
Pelvic Neoplasms | 1 | 2023 | 247 | 0.740 |
Why?
|
Laparoscopy | 10 | 2018 | 2035 | 0.720 |
Why?
|
Rhabdomyosarcoma | 1 | 2023 | 358 | 0.690 |
Why?
|
Kidney Pelvis | 4 | 2022 | 186 | 0.630 |
Why?
|
Radionuclide Imaging | 3 | 2020 | 1972 | 0.620 |
Why?
|
Cryptorchidism | 2 | 2021 | 151 | 0.610 |
Why?
|
Urologic Surgical Procedures | 5 | 2018 | 298 | 0.590 |
Why?
|
Chromatography, Liquid | 6 | 2020 | 983 | 0.540 |
Why?
|
Adrenalectomy | 1 | 2018 | 346 | 0.520 |
Why?
|
Urography | 4 | 2019 | 315 | 0.500 |
Why?
|
Proteins | 4 | 2013 | 6032 | 0.490 |
Why?
|
Urothelium | 1 | 2017 | 269 | 0.480 |
Why?
|
Urinary Bladder | 2 | 2023 | 1152 | 0.480 |
Why?
|
Cicatrix | 2 | 2020 | 798 | 0.460 |
Why?
|
Ureter | 4 | 2015 | 367 | 0.450 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2014 | 174 | 0.440 |
Why?
|
Bladder Exstrophy | 2 | 2022 | 106 | 0.440 |
Why?
|
Wilms Tumor | 1 | 2016 | 379 | 0.440 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2012 | 26 | 0.410 |
Why?
|
Lymph Node Excision | 2 | 2018 | 1271 | 0.410 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 506 | 0.410 |
Why?
|
Urogenital Abnormalities | 3 | 2019 | 261 | 0.370 |
Why?
|
Microwaves | 1 | 2012 | 185 | 0.360 |
Why?
|
Infant | 23 | 2021 | 36192 | 0.360 |
Why?
|
Urethral Stricture | 1 | 2010 | 50 | 0.360 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2223 | 0.350 |
Why?
|
Cystostomy | 2 | 2007 | 25 | 0.350 |
Why?
|
Child | 26 | 2023 | 80153 | 0.320 |
Why?
|
Child, Preschool | 22 | 2022 | 42230 | 0.320 |
Why?
|
Replantation | 1 | 2010 | 145 | 0.310 |
Why?
|
Ultrasonography | 7 | 2020 | 5972 | 0.300 |
Why?
|
Immunoglobulin G | 3 | 2014 | 4544 | 0.290 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2020 | 81 | 0.290 |
Why?
|
Ureteral Diseases | 1 | 2007 | 63 | 0.280 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2007 | 76 | 0.270 |
Why?
|
Cloaca | 1 | 2006 | 52 | 0.270 |
Why?
|
Kidney Transplantation | 4 | 2007 | 4234 | 0.260 |
Why?
|
Body Burden | 1 | 2006 | 158 | 0.260 |
Why?
|
Protein Processing, Post-Translational | 2 | 2013 | 1974 | 0.250 |
Why?
|
Proteinuria | 1 | 2008 | 607 | 0.250 |
Why?
|
Male | 44 | 2023 | 360804 | 0.250 |
Why?
|
Humans | 70 | 2023 | 761504 | 0.240 |
Why?
|
Urethral Obstruction | 2 | 2019 | 55 | 0.230 |
Why?
|
Kidney Neoplasms | 2 | 2018 | 4249 | 0.230 |
Why?
|
Propylene Glycols | 1 | 2003 | 91 | 0.220 |
Why?
|
Carbohydrate Sequence | 2 | 2014 | 411 | 0.220 |
Why?
|
Cattle | 3 | 2014 | 3849 | 0.220 |
Why?
|
Safety Management | 1 | 2008 | 760 | 0.210 |
Why?
|
Kidney Calculi | 1 | 2007 | 463 | 0.210 |
Why?
|
Radiation Protection | 1 | 2006 | 424 | 0.210 |
Why?
|
Testicular Neoplasms | 2 | 2021 | 799 | 0.210 |
Why?
|
Histocompatibility | 1 | 2003 | 317 | 0.200 |
Why?
|
Retroperitoneal Space | 2 | 2018 | 170 | 0.200 |
Why?
|
Urethra | 2 | 2019 | 405 | 0.200 |
Why?
|
Female | 37 | 2023 | 392644 | 0.200 |
Why?
|
Renal Artery | 1 | 2003 | 351 | 0.200 |
Why?
|
Blood Component Removal | 1 | 2002 | 132 | 0.190 |
Why?
|
Hernia, Umbilical | 1 | 2022 | 102 | 0.190 |
Why?
|
Uromodulin | 1 | 2021 | 44 | 0.190 |
Why?
|
Aneurysm, False | 1 | 2003 | 255 | 0.190 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2176 | 0.180 |
Why?
|
Fetal Diseases | 1 | 2006 | 913 | 0.180 |
Why?
|
Molecular Sequence Annotation | 2 | 2013 | 522 | 0.180 |
Why?
|
Creatinine | 3 | 2020 | 1899 | 0.180 |
Why?
|
Adolescent | 18 | 2022 | 88319 | 0.180 |
Why?
|
Feasibility Studies | 5 | 2020 | 5247 | 0.180 |
Why?
|
Mannose | 1 | 2020 | 121 | 0.170 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2022 | 459 | 0.170 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2020 | 67 | 0.170 |
Why?
|
Fucose | 1 | 2020 | 122 | 0.170 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2022 | 156 | 0.170 |
Why?
|
Fever | 2 | 2021 | 1618 | 0.170 |
Why?
|
Abnormalities, Multiple | 2 | 2022 | 1423 | 0.160 |
Why?
|
Radiation Injuries | 1 | 2006 | 1189 | 0.160 |
Why?
|
Pelvic Pain | 2 | 2021 | 298 | 0.160 |
Why?
|
Radiopharmaceuticals | 3 | 2020 | 2651 | 0.160 |
Why?
|
Cystectomy | 1 | 2023 | 634 | 0.150 |
Why?
|
Recurrence | 3 | 2020 | 8465 | 0.150 |
Why?
|
Contrast Media | 3 | 2020 | 5311 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2022 | 80636 | 0.150 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 527 | 0.150 |
Why?
|
Wounds, Nonpenetrating | 1 | 2003 | 807 | 0.140 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2019 | 269 | 0.140 |
Why?
|
Image Enhancement | 2 | 2020 | 2885 | 0.130 |
Why?
|
Receptors, Nicotinic | 1 | 2019 | 495 | 0.130 |
Why?
|
Pedigree | 3 | 2019 | 4542 | 0.130 |
Why?
|
Receptor, EphA2 | 1 | 2016 | 41 | 0.130 |
Why?
|
Algorithms | 4 | 2023 | 14031 | 0.130 |
Why?
|
Cohort Studies | 6 | 2020 | 41487 | 0.130 |
Why?
|
Sports | 1 | 2021 | 705 | 0.120 |
Why?
|
Endodermal Sinus Tumor | 1 | 2015 | 53 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14666 | 0.120 |
Why?
|
Urination Disorders | 2 | 2009 | 238 | 0.120 |
Why?
|
Silicon Dioxide | 1 | 2016 | 216 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2003 | 5671 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 989 | 0.120 |
Why?
|
Treatment Outcome | 13 | 2018 | 64680 | 0.120 |
Why?
|
Dogs | 6 | 2004 | 3839 | 0.120 |
Why?
|
Hematuria | 2 | 2007 | 233 | 0.120 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17635 | 0.110 |
Why?
|
Urinary Diversion | 2 | 2019 | 134 | 0.110 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 632 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 809 | 0.110 |
Why?
|
Spermatic Cord Torsion | 1 | 2013 | 72 | 0.110 |
Why?
|
Carbohydrate Conformation | 1 | 2013 | 206 | 0.110 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 469 | 0.100 |
Why?
|
Adult | 14 | 2022 | 221177 | 0.100 |
Why?
|
Ribonucleases | 1 | 2013 | 277 | 0.100 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 1860 | 0.100 |
Why?
|
Genes, Dominant | 1 | 2015 | 852 | 0.100 |
Why?
|
Animals | 19 | 2018 | 168459 | 0.100 |
Why?
|
Subcellular Fractions | 1 | 2013 | 532 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1668 | 0.100 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2012 | 149 | 0.090 |
Why?
|
Muscle, Smooth | 1 | 2015 | 926 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2021 | 1216 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 3029 | 0.090 |
Why?
|
Quality of Life | 2 | 2023 | 13367 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 4174 | 0.090 |
Why?
|
Molecular Weight | 1 | 2013 | 2186 | 0.090 |
Why?
|
Young Adult | 8 | 2022 | 59243 | 0.090 |
Why?
|
Transplantation Chimera | 2 | 2003 | 594 | 0.090 |
Why?
|
Catalysis | 1 | 2012 | 774 | 0.090 |
Why?
|
Methods | 1 | 2010 | 1067 | 0.090 |
Why?
|
Brain Concussion | 1 | 2021 | 1404 | 0.090 |
Why?
|
Syndrome | 3 | 2022 | 3267 | 0.090 |
Why?
|
Mass Screening | 2 | 2020 | 5428 | 0.090 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1787 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2020 | 26198 | 0.080 |
Why?
|
Blotting, Western | 1 | 2017 | 5035 | 0.080 |
Why?
|
Length of Stay | 3 | 2008 | 6425 | 0.080 |
Why?
|
Aging | 1 | 2008 | 8708 | 0.080 |
Why?
|
Chemical Precipitation | 1 | 2008 | 175 | 0.080 |
Why?
|
Biofeedback, Psychology | 1 | 2009 | 116 | 0.080 |
Why?
|
Postoperative Complications | 4 | 2018 | 15631 | 0.080 |
Why?
|
Ultrafiltration | 1 | 2008 | 49 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36426 | 0.080 |
Why?
|
Radiation Dosage | 3 | 2011 | 1958 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 283 | 0.080 |
Why?
|
Mutation | 3 | 2019 | 30052 | 0.080 |
Why?
|
Fluorocarbons | 1 | 2013 | 492 | 0.080 |
Why?
|
Prognosis | 5 | 2019 | 29625 | 0.080 |
Why?
|
Urolithiasis | 1 | 2009 | 125 | 0.070 |
Why?
|
Albumins | 1 | 2010 | 575 | 0.070 |
Why?
|
Up-Regulation | 1 | 2017 | 4124 | 0.070 |
Why?
|
Prospective Studies | 4 | 2022 | 54425 | 0.070 |
Why?
|
Peptides | 1 | 2020 | 4358 | 0.070 |
Why?
|
Nomograms | 1 | 2009 | 230 | 0.070 |
Why?
|
Freezing | 1 | 2008 | 311 | 0.070 |
Why?
|
Age Factors | 2 | 2018 | 18395 | 0.070 |
Why?
|
Urinalysis | 1 | 2009 | 368 | 0.070 |
Why?
|
Orchiectomy | 2 | 2021 | 463 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3466 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8631 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3492 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2898 | 0.060 |
Why?
|
Suture Techniques | 2 | 2008 | 769 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 1 | 2010 | 589 | 0.060 |
Why?
|
Urodynamics | 1 | 2006 | 346 | 0.060 |
Why?
|
Stents | 2 | 2007 | 3179 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9326 | 0.060 |
Why?
|
Risk Assessment | 3 | 2018 | 23995 | 0.060 |
Why?
|
Transplantation, Homologous | 5 | 2005 | 4806 | 0.060 |
Why?
|
Case Management | 1 | 2006 | 272 | 0.060 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2004 | 89 | 0.060 |
Why?
|
Fibronectins | 1 | 2008 | 723 | 0.060 |
Why?
|
Rats, Wistar | 1 | 2008 | 1848 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3612 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20570 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20098 | 0.060 |
Why?
|
Graft Survival | 3 | 2003 | 3819 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9351 | 0.050 |
Why?
|
Operating Rooms | 1 | 2010 | 789 | 0.050 |
Why?
|
Appendix | 1 | 2004 | 109 | 0.050 |
Why?
|
Cadherins | 1 | 2008 | 903 | 0.050 |
Why?
|
Dystrophin | 1 | 2004 | 283 | 0.050 |
Why?
|
Isoantigens | 1 | 2005 | 551 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2004 | 899 | 0.050 |
Why?
|
Orchiopexy | 1 | 2021 | 20 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39106 | 0.050 |
Why?
|
Sphingosine | 1 | 2003 | 308 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5492 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2003 | 778 | 0.050 |
Why?
|
Congenital Abnormalities | 1 | 2006 | 709 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2011 | 1998 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2003 | 479 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2005 | 1435 | 0.050 |
Why?
|
Graft Rejection | 2 | 2005 | 4445 | 0.050 |
Why?
|
Kidney Function Tests | 1 | 2003 | 678 | 0.050 |
Why?
|
Cyclosporine | 1 | 2003 | 778 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5112 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 2002 | 329 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4063 | 0.040 |
Why?
|
Reoperation | 2 | 2007 | 4303 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3816 | 0.040 |
Why?
|
Middle Aged | 4 | 2020 | 220895 | 0.040 |
Why?
|
Mouth Mucosa | 1 | 2022 | 432 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2192 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6240 | 0.040 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2022 | 284 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2013 | 18252 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16981 | 0.040 |
Why?
|
Short Bowel Syndrome | 1 | 2002 | 353 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2002 | 11118 | 0.040 |
Why?
|
Software | 1 | 2013 | 4434 | 0.040 |
Why?
|
Urinary Catheterization | 1 | 2019 | 193 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3801 | 0.040 |
Why?
|
Transplantation Tolerance | 1 | 2003 | 605 | 0.040 |
Why?
|
Infant Care | 1 | 2019 | 180 | 0.040 |
Why?
|
Ultrasonography, Prenatal | 1 | 2006 | 1755 | 0.040 |
Why?
|
Genes | 1 | 2002 | 1823 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2006 | 22176 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22169 | 0.040 |
Why?
|
CpG Islands | 1 | 2002 | 1230 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 1997 | 54 | 0.040 |
Why?
|
Tissue Donors | 2 | 2005 | 2331 | 0.030 |
Why?
|
Motion | 1 | 2020 | 779 | 0.030 |
Why?
|
Rats | 2 | 2016 | 23742 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17904 | 0.030 |
Why?
|
Vagina | 1 | 2022 | 838 | 0.030 |
Why?
|
Intestine, Small | 1 | 2002 | 1206 | 0.030 |
Why?
|
Acute Disease | 2 | 2005 | 7237 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1533 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2005 | 1310 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2693 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1265 | 0.030 |
Why?
|
Physician's Role | 1 | 2002 | 917 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2015 | 293 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 39967 | 0.030 |
Why?
|
Brachytherapy | 1 | 2002 | 1223 | 0.030 |
Why?
|
Risk | 1 | 2006 | 9610 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1137 | 0.030 |
Why?
|
Prostatectomy | 1 | 2002 | 1824 | 0.030 |
Why?
|
Bone Screws | 1 | 1997 | 532 | 0.030 |
Why?
|
Base Sequence | 3 | 2015 | 12441 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2281 | 0.030 |
Why?
|
Whole-Body Irradiation | 2 | 2004 | 433 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2606 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2015 | 878 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1539 | 0.030 |
Why?
|
Swine, Miniature | 2 | 2005 | 961 | 0.030 |
Why?
|
Artifacts | 1 | 2020 | 1911 | 0.020 |
Why?
|
Sequence Analysis, Protein | 1 | 2013 | 261 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2002 | 1421 | 0.020 |
Why?
|
Swine | 3 | 2008 | 5915 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3589 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 931 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1611 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 1997 | 980 | 0.020 |
Why?
|
Chronic Disease | 2 | 2021 | 9318 | 0.020 |
Why?
|
Survival Analysis | 1 | 2003 | 10090 | 0.020 |
Why?
|
Radioisotope Renography | 1 | 2010 | 61 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1784 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3810 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3233 | 0.020 |
Why?
|
Joint Instability | 1 | 1997 | 801 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1893 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16591 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2009 | 384 | 0.020 |
Why?
|
Survival Rate | 1 | 2003 | 12725 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 348 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2628 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2645 | 0.020 |
Why?
|
DNA Methylation | 1 | 2002 | 4398 | 0.020 |
Why?
|
Spinal Fusion | 1 | 1997 | 1286 | 0.020 |
Why?
|
Rabbits | 1 | 2013 | 4772 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3595 | 0.020 |
Why?
|
Urinary Bladder Diseases | 1 | 2008 | 167 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 966 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2020 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2471 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3514 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15266 | 0.020 |
Why?
|
United States | 3 | 2021 | 72334 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 21353 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 825 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2010 | 947 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4278 | 0.020 |
Why?
|
Electron Transport | 1 | 2006 | 210 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2006 | 353 | 0.020 |
Why?
|
Leukocytes | 2 | 2004 | 2026 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15842 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2006 | 532 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1186 | 0.020 |
Why?
|
Ileum | 1 | 2008 | 557 | 0.020 |
Why?
|
Electrons | 1 | 2006 | 265 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2006 | 189 | 0.020 |
Why?
|
Aged | 1 | 2018 | 169289 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2004 | 4615 | 0.020 |
Why?
|
Mice | 4 | 2018 | 81525 | 0.010 |
Why?
|
Lectins | 1 | 2006 | 491 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4740 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 2005 | 490 | 0.010 |
Why?
|
Leukapheresis | 1 | 2003 | 134 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6766 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13506 | 0.010 |
Why?
|
Multifactorial Inheritance | 1 | 2010 | 1387 | 0.010 |
Why?
|
Histocompatibility Antigens | 1 | 2003 | 464 | 0.010 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2002 | 53 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2003 | 523 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11076 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2004 | 13446 | 0.010 |
Why?
|
Isoantibodies | 1 | 2005 | 674 | 0.010 |
Why?
|
Chromosomes | 1 | 2004 | 577 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3429 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2004 | 815 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6180 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2002 | 1058 | 0.010 |
Why?
|
Immunization | 1 | 2005 | 1228 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29874 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3357 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11121 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14414 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2748 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12974 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4174 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1349 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2002 | 1163 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 74206 | 0.010 |
Why?
|
Species Specificity | 1 | 2002 | 2414 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4575 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12059 | 0.010 |
Why?
|
Ilium | 1 | 1997 | 155 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1600 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 6374 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 7967 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2002 | 2049 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6310 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1997 | 2115 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7407 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10766 | 0.010 |
Why?
|
Heart | 1 | 2003 | 4404 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10445 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 26125 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4948 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10194 | 0.000 |
Why?
|
Lung | 1 | 2005 | 10000 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11903 | 0.000 |
Why?
|
Transcription Factors | 1 | 2002 | 12128 | 0.000 |
Why?
|